Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 135,817 | -9,602 | -16,750 | -77,069 | -81,153 |
| Depreciation Amortization | 15,934 | 5,843 | 5,892 | 6,175 | 4,084 |
| Income taxes - deferred | -153,159 | 0 | N/A | N/A | N/A |
| Accounts receivable | 3,588 | -432 | -478 | -147 | 21,565 |
| Other Working Capital | 3,786 | -13,304 | -857 | -2,656 | 61,120 |
| Other Operating Activity | 5,448 | 10,721 | 11,036 | 9,893 | -7,143 |
| Operating Cash Flow | $11,414 | $-6,774 | $-1,157 | $-63,804 | $-1,527 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 159,821 | N/A | N/A | N/A | N/A |
| PPE Investments | -44 | 1,338 | -47 | -507 | -1,223 |
| Net Acquisitions | -595,602 | -3,434 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -115,046 | -149,406 | -126,585 | -262,597 |
| Sale Of Investment | N/A | 106,030 | 133,061 | 141,095 | 160,079 |
| Other Investing Activity | 2,883 | -2,823 | 0 | 0 | 0 |
| Investing Cash Flow | $-432,942 | $-13,935 | $-16,392 | $14,003 | $-103,741 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 527,509 | 0 | N/A | N/A | N/A |
| Debt Repayment | -39,760 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 34,119 | 1,453 | 368 | 629 | 167,788 |
| Other Financing Activity | -8,030 | -51 | 0 | 0 | 0 |
| Financing Cash Flow | $513,838 | $1,402 | $368 | $629 | $167,788 |
| Beginning Cash Position | 26,986 | 46,293 | 63,474 | 112,646 | 50,126 |
| End Cash Position | 119,296 | 26,986 | 46,293 | 63,474 | 112,646 |
| Net Cash Flow | $92,310 | $-19,307 | $-17,181 | $-49,172 | $62,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,414 | -6,774 | -1,157 | -63,804 | -1,527 |
| Capital Expenditure | -44 | 1,338 | -47 | -507 | -1,223 |
| Free Cash Flow | 11,370 | -5,436 | -1,204 | -64,311 | -2,750 |